Abstract
Clear diagnostic criteria and definitions of coronary artery lesions (CALs) were established in Japan by the Japanese Ministry of Health Research Committee (Fifth Revised Edition, February 2002) and the Japanese Circulation Society (JCS), and in the United States by the American Heart Association (AHA) and American Academy of Pediatrics (AAP), in 2004. Definitions and criteria for Kawasaki disease diagnosis slightly differ between the AHA/AAP and Japanese guidelines. The diagnostic criteria for classical Kawasaki disease in AHA/AAP guidelines include fever persisting at least 5 days and at least four of five other criteria. The criteria in the Japanese guidelines include fever as a sixth, equally important criterion, and patients must meet five of six criteria for diagnosis, including fever that subsides within 5 days in response to therapy. It is difficult to compare CAL rates in these countries because the definitions of CALs are completely different in the respective guidelines. The Japanese JCS guidelines for CALs use the diameter of each segment of coronary arteries. However, in the AHA/APP guidelines aneurysms are classified using z-scores. Previously reported differences in CAL rates between the United States and Japan likely resulted from use of different definitions and nomenclature. Development of standard criteria for CALs in both countries would allow meaningful comparisons between countries and facilitate collaborative international clinical trials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int. 2005;47(2):232–4.
Japanese Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Pediatr Int. 2005;47(6):711–32. http://dx.doi.org/10.1111/j.1442-200x.2005.02149.x PMID:16354233.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Committee on rheumatic fever, endocarditis and Kawasaki disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110(17):2747–71. http://dx.doi.org/10.1161/01.CIR.0000145143.19711.78 PMID:15505111.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114(6):1708–33. http://dx.doi.org/10.1542/peds.2004-2182 PMID:15574639.
Bayers S, Shulman ST, Paller AS. Kawasaki disease: Part I. Diagnosis, clinical features, and pathogenesis. J Am Acad Dermatol. 2013;69(4):501 e1–11; quiz 11–2.
Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22(2):79–85.
Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011–2012: from the results of the 22nd nationwide survey. J Epidemiol. 2015;25(3):239–45.
Sonobe T, Kiyosawa N, Tsuchiya K, Aso S, Imada Y, Imai Y, et al. Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int. 2007;49(4):421–6. http://dx.doi.org/10.1111/j.1442-200X.2007.02396.x.
Yellen ES, Gauvreau K, Takahashi M, Burns JC, Shulman S, Baker AL, et al. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics. 2010;125(2):e234–41. http://dx.doi.org/10.1542/peds.2009-0606 PMID:20100771.
Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. 2008;153(1):117–21. http://dx.doi.org/10.1016/j.jpeds.2007.12.021 PMID:18571548.
Ogata S, Tremoulet AH, Sato Y, Ueda K, Shimizu C, Sun X, et al. Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol. 2013;168(4):3825–8. http://dx.doi.org/10.1016/j.ijcard.2013.06.027 PMID:23849968.
Dallaire F, Dahdah N. New equations and a critical appraisal of coronary artery Z scores in healthy children. J Am Soc Echocardiogr. 2011;24(1):60–74. http://dx.doi.org/10.1016/j.echo.2010.10.004 PMID:21074965.
Manlhiot C, Millar K, Golding F, McCrindle BW. Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol. 2010;31(2):242–9. http://dx.doi.org/10.1007/s00246-009-9599-7 PMID:20024653.
de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 1998;133(2):254–8. http://dx.doi.org/10.1016/S0022-3476(98)70229-X PMID:9709715.
Belay ED, Maddox RA, Holman RC, Curns AT, Ballah K, Schonberger LB. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994–2003. Pediatr Infect Dis J. 2006;25(3):245–9. http://dx.doi.org/10.1097/01.inf.0000202068.30956.16 PMID:16511388.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Japan
About this chapter
Cite this chapter
Ogata, S. (2017). Kawasaki Disease Diagnosis and Complication Rates in the United States and Japan. In: Saji, B., Newburger, J., Burns, J., Takahashi, M. (eds) Kawasaki Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56039-5_24
Download citation
DOI: https://doi.org/10.1007/978-4-431-56039-5_24
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-56037-1
Online ISBN: 978-4-431-56039-5
eBook Packages: MedicineMedicine (R0)